Results 41 to 50 of about 474,365 (309)

Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study

BMC Cancer, 2023
Background Non-metastatic breast cancer treatment is mainly based on surgery, with or without chemotherapy, radiotherapy and/or hormone therapy. To reduce the risk of hormone receptor positive (HR+) disease recurrence, hormone therapy is prescribed for ...
François Gernier, Jean-Michel Grellard, Charlotte Dupont, Hervé Castel, Marie Fernette, François Lahaye, Rose-Marie Charles, Tiphaine Leroux, Céline Ory, Audrey Faveyrial, Adeline Morel, George Emile, Christelle Levy, Carine Segura, Djelila Allouache, Alison Johnson, Julien Geffrelot, Katharina Gunzer, Anaïs Lelaidier, Gilles Girault, Coraline Dubot-poitelon, Chankannira San, Justine Lequesne, Bénédicte Clarisse   +23 more
doaj   +1 more source

Correction of menopausal disorders: new possibilities of menopausal hormone therapy

Медицинский совет, 2022
Determining the role of menopausal hormone therapy in the era of covid infection is an urgent task. The reasons for the lower rate of severe outcomes in women against the background of covid infection compared to men are currently being discussed.
L. Yu. Karakhalis
doaj   +1 more source

Effect of Growth Hormone (hGH) Replacement Therapy on Physical Work Capacity and Cardiac and Pulmonary Function in Patients with hGH Deficiency Acquired in Adulthood. [PDF]

, 1995
The effects of 6 months of replacement therapy with recombinant human GH (hGH) on physical work capacity and cardiac structure and function were investigated in 20 patients with hGH deficiency of adult onset in a double blind, placebo-controlled trial ...
Schopohl, Jochen, Nass, Ralf, Strasburger, Christian J., Klauss, Volker, Müller, Otto A., Huber, Rudolf M.   +5 more
core   +1 more source

Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper

, 2021
Introduction Hormone replacement therapy (HRT) can help women experiencing menopausal symptoms, but usage has declined due to uncertainty around risks of cancer and some cardiovascular diseases (CVD).
Winnie Xue Mei, Hippisley-Cox, J, Cardwell, Christopher Robert, Burchardt, J, Carol Coupland, Cardwell, CR, Clift, Ashley Kieran, Tom Alan Ranger, Tan, PS, Cardwell, Christopher Robert; id_orcid, Judith Burchardt, Ranger, Tom Alan, Ranger, TA, Coupland, C, Sharon Dixon, Dixon, S, Coupland, Carol, Mei, Winnie Xue, Dixon, Sharon, Christopher Robert Cardwell, Pui San Tan, Julia Hippisley-Cox, Mei, WX, Hippisley-Cox, Julia, Tan, Pui San, Clift, AK, Burchardt, Judith, Ashley Kieran Clift   +27 more
core   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study

BMC Women's Health, 2023
Background Menopause is a specific physical and psychological transition period for women, during which they experience a series of menopausal symptoms. Menopausal hormone therapy is an important treatment for improving menopausal symptoms. Helping women
Jie Lu, Kangfen Li, Xinlie Zheng, Ran Liu, Min Chen, Jingyun Xian, Suhua Tu, Lingling Xie   +7 more
doaj   +1 more source

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. [PDF]

, 2002
OBJECTIVE: To determine the effects of antiplatelet therapy among patients at high risk of occlusive vascular events. DESIGN: Collaborative meta-analyses (systematic overviews).
M. Catalano, Mccollum, Charles, Collaboration, Antithrombotic Trialists', Antithrombotic Trialists' Collaboration, Antithrombotic Trialists', Baigent, C, Collins, R, McCollum, CN, Antithrombotic Trialists' Collaboration, Sudlow, C, Peto, R   +9 more
core   +1 more source

Transferrin receptor 1‐mediated iron uptake supports thermogenic activation in human cervical‐derived adipocytes

FEBS Letters, EarlyView.
In this study, we found that human cervical‐derived adipocytes maintain intracellular iron level by regulating the expression of iron transport‐related proteins during adrenergic stimulation. Melanotransferrin is predicted to interact with transferrin receptor 1 based on in silico analysis.
Rahaf Alrifai, Mizuki Seo, Gyath Karadsheh, Fachrur Rizal Mahendra, Máté Á Demény, Ferenc Győry, János András Mótyán, László Fésüs, Endre Kristóf, Rini Arianti   +9 more
wiley   +1 more source

Hormone therapy for first-line management of menopausal symptoms: Practical recommendations

Women's Health, 2019
Hormone therapy use has undergone dramatic changes over the past 20 years. Widespread use of hormone therapy in the 1980s and 1990s came to an abrupt halt in the early 2000s after initial findings of the Women’s Health Initiative trial were published and
Santiago Palacios, John C Stevenson, Katrin Schaudig, Monika Lukasiewicz, Alessandra Graziottin   +4 more
doaj   +1 more source

History of growth hormone therapy

Indian Journal of Endocrinology and Metabolism, 2011
Although the importance of the pituitary gland for growth was recognized in late 19 th century, Growth hormone (GH) therapy was made available for severely GH-deficient children and adolescents only in late 1950s.
Vageesh S Ayyar
doaj   +1 more source